Oral neomycin dosage schedules for suppression of ammonia production by bowel flora.

Antimicrobial Agents and Chemotherapy
B SuhC M Kunin

Abstract

To better define a minimal but optimal dose of oral neomycin to suppress ammonia production by bowel flora, several dosage regimens were examined in normal healthy volunteers. Fecal urease activity was quantitatively determined and was used as an indirect measure of intrinsic ammonia production by bowel flora. Large doses of neomycin were found to exert inhibition of fecal urease for many days. There was considerable variation in enzymatic activity among subjects even after adjustments were made for protein content of the stool. Depending on the dose, there was a 1- to 3-day lag in neomycin effect on stool urease activity and several days of continued effect. The most effective regimen of those studied was a loading dose of 6 g of neomycin given in three divided doses on day 1, followed by 1 g twice daily.

References

Apr 1, 1972·Southern Medical Journal·V V Kalbian
Oct 18, 1965·JAMA : the Journal of the American Medical Association·C W Fink
Jul 23, 1970·The New England Journal of Medicine·E WolpertW H Summerskill
May 1, 1970·The Annals of Thoracic Surgery·M MyersonT L Curran
Sep 1, 1970·Annals of Internal Medicine·D P Berk, T Chalmers
Jan 1, 1968·The American Journal of the Medical Sciences·W O DobbinsC M Mansbach
Jun 12, 1969·The New England Journal of Medicine·D R KellyR B Berggren
Dec 21, 1957·Lancet·A M DAWSONS SHERLOCK
Feb 25, 1960·The New England Journal of Medicine·P M LAST, S SHERLOCK

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.